Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.06% Nasdaq Down0.01%

Achillion Pharmaceuticals, Inc. (ACHN)

-NasdaqGS

7.58 Down 0.06(0.79%) 4:00PM EDT|After Hours : 7.64 Up 0.06 (0.79%) 5:00PM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 30, 2013Dec 30, 2012Sep 29, 2012Jun 29, 2012
Total Revenue -   118   -   -  
Cost of Revenue -   -   -   -  
Gross Profit -   118   -   -  
Operating Expenses
Research Development8,719  8,437  12,641  8,979  
Selling General and Administrative3,074  2,936  2,647  2,579  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (11,793) (11,255) (15,288) (11,558)
Income from Continuing Operations
Total Other Income/Expenses Net77  66  49  54  
Earnings Before Interest And Taxes(11,716)(11,189)(15,239)(11,504)
Interest Expense22  15  16  23  
Income Before Tax(11,738)(11,204)(15,255)(11,527)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(11,738)(11,204)(15,255)(11,527)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (11,738) (11,204) (15,255) (11,527)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (11,738) (11,204) (15,255) (11,527)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.